March 15, 2011 – A new chromium cobalt stent has received the CE mark market clearance in Europe. The Azule cobalt chromium stent, from OrbusNeich, combines the stent design of the its predecessor, the Blazer, with a delivery system with enhanced crossability and flexible deliverability.
The stent features the company’s dual helix design, offering conformability and radial strength on thin, flexible and low-profile cobalt chromium stent struts. The stent's tip length has been reduced from 5 mm to 4.25 mm, improving deliverability and crossability. The precise laser forming of the tip results in a lower lesion entry profile, and the controlled laser welding of the balloon to the catheter improves the stent's trackability and flexibility.
"Continuous technology advancement is mandated by our customers and the very nature of interventional cardiology," said Al Novak, OrbusNeich's chairman and CEO. "We believe the underlying deliverability of a stent is, and will continue to be, a critically important factor that we strive to improve."
For more information: www.OrbusNeich.com